Job ID: 61710
Location: Wien, AT Springe, DE Stockholm, SE Lingolsheim, FR
Job Level: Professionals
Job Category: Technical
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately‑owned company, where the warmth of family meets the scale of a global organisation.
To strengthen our global engineering capabilities, we are looking for a Group Senior Process Engineer who will play a key role in major international investment projects and help shape the future of our pharmaceutical manufacturing landscape.
In this role, you will be responsible for the design and development of process systems and equipment. You will contribute to large‑scale CAPEX projects, including greenfield plant developments, ensuring best‑in‑class engineering solutions that align with Octapharma’s group strategy.
The position will be filled in Vienna (Austria), Springe (Germany), Stockholm (Sweden) or Lingolsheim (France).
Join us in shaping our vision of providing new health solutions advancing human life.
You will thrive in this role if you can take full ownership of greenfield projects, driving process development from concept to implementation with a self‑driven mindset.
The minimum gross salary according to the collective agreement (chemical industry) is EUR 4,270.14 based on 38 hours per week (full‑time). As we strive to offer a salary that reflects your individual profile and qualifications, there is a willingness to pay above the minimum salary.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application – regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state‑of‑the‑art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.